Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news


From To
Short-cycle intermittent HAART maintains undetectable viral load, but does not increase CD4 counts

A small proof-of-concept study has shown that once-daily treatment with ddI (didanosine), 3TC (lamivudine) and efavirenz in a week on, week off (WOWO) regimen effectively

03 June 2004
Christopher Gadd
Stopping nevirapine five days prior to nucleosides may avoid resistance

Stopping the nevirapine component of nevirapine-based HAART five days prior to the nucleoside backbone when stopping or interrupting treatment appears to be a “reasonable strategy”

20 May 2004
Edwin J. Bernard
Differences found between patients stopping HAART for medical or lifestyle reasons

HIV-positive individuals who take a break from their anti-HIV treatment for medical reasons have different motives and characteristics to patients who are motivated to temporarily

04 March 2004
Michael Carter
← Prev1...678910Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.